← Eichor
Study identifier: NCT04037007 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Fistulotomy for Biliary Cannulation

Condition: Cholangiocarcinoma · Choledocholithiasis; Cholangitis · Pancreatic Cancer  ·  Sponsor: Coordinación de Investigación en Salud, Mexico

PhaseNA
Planned participants320
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

Access to the main bile duct is the first step in order to perform a therapeutic maneuver for biliary diseases. Early precut has been shown to ameliorate cannulation success rate, specially in difficult cannulation cases, when compared to guidewire cannulation (which is considered, for most, the standard technique). We aim to perform a randomized clinical trial comparing fistulotomy (F) precut vs guidewire cannulation (CC), as a primary cannulation technique, and compare outcomes between high experienced endoscopists (\> 200 ERCPs\[Endoscopic Retrograde cholangiopancreatography\]) and low experienced endoscopists (\< 200 ERCPs).

This description comes directly from the study's public registry record.

Talk to the study team

Oscar V Hernández Mondragón, MD  ·  +525556276900  ·  mondragonmd@yahoo.co.uk

Carlos Mendoza Segura, Fellow  ·  +525556276900  ·  carlosms.gastro@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Centro Medico Nacional Siglo XXI Hospital de EspecialidadesMexico City, Mexico City, MexicoRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04037007